Accessibility Menu
AtaiBeckley logo

AtaiBeckley

(NASDAQ) ATAI

Current Price$3.94
Market Cap$1.45B
Since IPO (2021)-80%
5 YearN/A
1 Year+59%
1 Month-5%

AtaiBeckley Financials at a Glance

Market Cap

$1.45B

Revenue (TTM)

$3.49M

Net Income (TTM)

-$663.40M

EPS (TTM)

-$2.24

P/E Ratio

-1.76

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$3.94

Volume

9,240,989.504

Open

$4.46

Previous Close

$3.95

Daily Range

$3.78 - $4.49

52-Week Range

$2.00 - $6.75

Estimated Earnings Date

Aug 13, 2026

ATAI: Motley Fool Moneyball Superscore

47

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About AtaiBeckley

Industry

Pharmaceuticals

Employees

117

CEO

Srinivas G. Rao, MD, PhD

Headquarters

New York, NY 10119, US

ATAI Financials

Key Financial Metrics (TTM)

Gross Margin

82%

Operating Margin

-37%

Net Income Margin

-190%

Return on Equity

0%

Return on Capital

-53%

Return on Assets

-3%

Earnings Yield

-56.82%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.45B

Shares Outstanding

368.17M

Volume

9.24M

Avg. Volume

5.83M

Financials (TTM)

Gross Profit

$3.08M

Operating Income

-$99.76M

EBITDA

-$98.75M

Operating Cash Flow

-$102.68M

Capital Expenditure

-$901.00K

Free Cash Flow

-$103.58M

Cash & ST Invst.

$256.04M

Total Debt

$2.07M

AtaiBeckley Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$954.00K

-38.6%

Gross Profit

$787.00K

-41.2%

Gross Margin

82.49%

N/A

Market Cap

$1.45B

N/A

Market Cap/Employee

$14.69M

N/A

Employees

99

N/A

Net Income

-$29.78M

-12.7%

EBITDA

-$30.73M

-52.5%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Net Cash

$228.77M

+219.8%

Accounts Receivable

$14.71M

+887.2%

Inventory

$0.00

N/A

Long Term Debt

$1.69M

-85.8%

Short Term Debt

$310.00K

-97.9%

Return on Assets

-2.50%

N/A

Return on Invested Capital

-53.18%

N/A

Free Cash Flow

-$21.09M

-16.5%

Operating Cash Flow

-$21.09M

-18.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SNDXSyndax Pharmaceuticals, Inc.
$17.34-3.77%
IMTXImmatics N.V.
$9.79-3.83%
INBXInhibrx Biosciences, Inc.
$87.01-4.65%
NKTRNektar Therapeutics
$57.32-3.36%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$14.38-0.13%
TQQQProShares Trust - ProShares UltraPro Qqq
$73.05-0.14%
KEELKeel Infrastructure
$5.13-0.13%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$43.19+0.14%

Questions About ATAI

What is the current price of AtaiBeckley?

AtaiBeckley is trading at $3.95 per share.

What is the 52-week range for AtaiBeckley?

Over the past 52 weeks, AtaiBeckley has traded between $2.00 and $6.75.

How much debt does AtaiBeckley have?

As of the most recent reporting period, AtaiBeckley reported total debt of $2.00M.

How much cash does AtaiBeckley have on hand?

AtaiBeckley reported $43.10M in cash and cash equivalents in its most recent financial results.

What is AtaiBeckley’s dividend yield?

AtaiBeckley does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.